- Home
- SWX vs LYEL Comparison
SWX vs LYEL Comparison
Compare SWX & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWX
- LYEL
- Stock Information
- Founded
- SWX 1931
- LYEL 2018
- Country
- SWX United States
- LYEL United States
- Employees
- SWX N/A
- LYEL N/A
- Industry
- SWX Oil & Gas Production
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- SWX Utilities
- LYEL Health Care
- Exchange
- SWX Nasdaq
- LYEL Nasdaq
- Market Cap
- SWX 5.5B
- LYEL 207.7M
- IPO Year
- SWX N/A
- LYEL 2021
- Fundamental
- Price
- SWX $73.74
- LYEL $9.43
- Analyst Decision
- SWX Hold
- LYEL Sell
- Analyst Count
- SWX 3
- LYEL 2
- Target Price
- SWX $75.67
- LYEL $15.00
- AVG Volume (30 Days)
- SWX 512.4K
- LYEL 311.0K
- Earning Date
- SWX 08-05-2025
- LYEL 08-06-2025
- Dividend Yield
- SWX 3.36%
- LYEL N/A
- EPS Growth
- SWX 16.20
- LYEL N/A
- EPS
- SWX 3.12
- LYEL N/A
- Revenue
- SWX $4,827,986,000.00
- LYEL $65,000.00
- Revenue This Year
- SWX $1.05
- LYEL N/A
- Revenue Next Year
- SWX $3.95
- LYEL N/A
- P/E Ratio
- SWX $23.62
- LYEL N/A
- Revenue Growth
- SWX N/A
- LYEL N/A
- 52 Week Low
- SWX $64.31
- LYEL $7.65
- 52 Week High
- SWX $80.29
- LYEL $38.40
- Technical
- Relative Strength Index (RSI)
- SWX 52.51
- LYEL 50.01
- Support Level
- SWX $73.57
- LYEL $8.46
- Resistance Level
- SWX $75.93
- LYEL $9.80
- Average True Range (ATR)
- SWX 1.31
- LYEL 0.90
- MACD
- SWX 0.08
- LYEL -0.09
- Stochastic Oscillator
- SWX 53.89
- LYEL 38.80
About SWX Southwest Gas Holdings Inc. (DE)
Southwest Gas Holdings Inc is a utility company engaged in the purchasing, distributing, and transporting of natural gas in the American Southwest. The company segments its activities into natural gas distribution and Utility Infrastructure Services units. The first of these encompasses the company's core natural gas business as distributors in the states of Arizona and Nevada. The natural gas distribution division is responsible for roughly half of Southwest Gas' total revenue through the sale of natural gas to mainly residential and small commercial customers. The Utility Infrastructure Services segment generates the other half of the company's total revenue from the underground piping contractor services that its subsidiary, Centuri Construction Group, provides.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.